掌骨骨折术后早期应用三七接骨丸的临床疗效观察

发布时间：2018-03-19 21:45

本文选题：掌骨骨折　切入点：三七接骨丸　出处：《湖南中医药大学》2016年硕士论文　论文类型：学位论文

【摘要】：【目的】:观察掌骨骨折术后早期应用三七接骨丸的临床疗效。【方法】:符合纳入标准的掌骨骨折患者60例随机分为治疗组和对照组,每组各30例。经手术切开骨折复位微型钢板内固定治疗后,从术后首日开始,治疗组给予三七接骨丸口服,每次6克,每日3次;对照组给予骨肽片口服,每次2片,每日3次,2周为1疗程,用药2个疗程,共4周。在术后不同阶段,分别对患肢疼痛、肿胀、骨折愈合情况、手部功能恢复情况四个方面进行观察记录,并将数据进行统计学分析。分别于术后第3天、1周、2周,参照VAS疼痛视觉模拟评分和手部肿胀分级评定标准对患肢局部疼痛程度、肿胀情况进行评分;于术后第2周、4周、6周,通过手部X光片进行骨愈合情况评分;于术后第4周、8周、12周,根据参照TAFS评分标准进行手部功能评分。【结果】:1、术后第3天、1周,治疗组的疼痛评分低于对照组,存在统计学差异(P0.05);术后第2周两组间疼痛评分无统计学差异(P0.05)。2、术后第3天、1周、2周,治疗组的肿胀评分均低于对照组,存在统计学差异(P0.05)。3、术后第2周,两组的X线评分无统计学差异(P0.05);术后第4周、6周,治疗组的骨愈合情况X线评分低于对照组,存在统计学差异(P0.05)。4、术后第4周、8周、12周,治疗组的手部功能恢复情况均优于对照组,存在统计学差异(P0.05)。【结论】:掌骨骨折术后早期应用三七接骨丸,能够有效减轻疼痛、消除肿胀,促进骨折愈合,促进患手功能恢复,是临床治疗掌骨骨折的有效药物。
[Abstract]:[objective]: to observe the clinical effect of Sanqi Jiegu Pill in the early postoperative period of metacarpal fracture. [methods] Sixty patients with metacarpal fracture who met the inclusive criteria were randomly divided into treatment group and control group. 30 cases in each group were treated by open reduction and mini-plate internal fixation. From the first day after operation, the treatment group was given Sanqi Jiegu pills orally, 6 grams each time, 3 times a day, while the control group was given two tablets of osteopeptide tablets each time. Three times a day for 2 weeks and two courses for 4 weeks. Pain, swelling, fracture healing and recovery of hand function were observed and recorded at different stages of operation. Statistical analysis of the data was made. According to VAS visual analogue score and hand swelling grading standard, the local pain degree and swelling status of the affected limb were evaluated on the 3rd day and 2nd week after operation, and 6 weeks from 4 weeks to 6 weeks after the operation, and 4 weeks after operation, 6 weeks after operation, 4 weeks after operation, 6 weeks after operation, 4 weeks after operation, 4 weeks after operation, 6 weeks after operation. The score of bone healing was evaluated by X-ray film of hand, and the score of hand function was evaluated according to the TAFS scoring standard at the 4th week and the 12th week after operation. [results] the pain score of the treatment group was lower than that of the control group at 1: 1, 3 days after operation, 1 week after operation, and 12 weeks after the operation, the pain score of the treatment group was lower than that of the control group. There was no significant difference in pain scores between the two groups at the second week after operation (P 0.05), and the swelling scores in the treatment group were lower than those in the control group at 1 week and 2 weeks after operation, and there was statistical difference between the two groups at the second week after operation, and at the second week after operation, the swelling scores in the treatment group were lower than those in the control group. There was no significant difference in X-ray score between the two groups (P 0.05), but the X-ray score of bone healing in the treatment group was lower than that in the control group at the 4th week and the 6th week after operation, and there was a statistical difference between the two groups (P 0.05). The recovery of hand function in the treatment group was better than that in the control group (P 0.05). [conclusion] early application of Sanqi Jiegu Pill after metacarpal fracture can effectively relieve pain, eliminate swelling, promote fracture healing and promote recovery of hand function. It is an effective drug for the treatment of metacarpal fracture.
【学位授予单位】：湖南中医药大学
【学位级别】：硕士
【学位授予年份】：2016
【分类号】：R274.1

【相似文献】